the impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases英夫利昔单抗治疗的影响炎症风湿性疾病患者的生活质量.pdf
文本预览下载声明
Available online /content/9/5/R103
Vol 9 No 5 Open Access
Research article
The impact of infliximab treatment on quality of life in patients
with inflammatory rheumatic diseases
1 2 3 4 5
Chenglong Han , Josef S Smolen , Arthur Kavanaugh , Désirée van der Heijde , Jürgen Braun ,
6 1 1 1 1
René Westhovens , Ning Zhao , Mahboob U Rahman , Daniel Baker and Mohan Bala
1Centocor Research and Development, Inc., 200 Great Valley Parkway, Malvern, Pennsylvania, 19355 USA
2Division of Rheumatology, Internal Medicine III, Medical University of Vienna and Hietzing Hospital, Waehringer Guertel 18-20, A-1090, Vienna,
Austria
3Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, 9500 Gilman Drive, LaJolla, California, 92093 USA
4Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
5Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, D-44652 Herne, Germany
6Division of Rheumatology, UZ Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
Corresponding author: Chenglong Han, chan3@
Received: 30 Mar 2007 Revisions requested: 25 May 2007 Revisions received: 16 Aug 2007 Accepted: 8 Oct 2007 Published: 8 Oct 2007
Arthritis Research Therapy 2007, 9:R103 (doi:10.1186/ar2306)
This article is online at: /content/9/5/R103
© 2007 Chenglong Han et al.; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by
显示全部